当前位置:首页 - 行情中心 - 澳洋健康(002172) - 财务分析 - 现金流量表

澳洋健康

(002172)

  

流通市值:37.42亿  总市值:37.44亿
流通股本:7.65亿   总股本:7.66亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金579,190,484.36261,832,123.11,733,661,841.41,175,130,526.65
  收到的税费返还0--439,253.38
  收到其他与经营活动有关的现金71,092,321.17117,080,138.07197,483,825.67184,582,195.03
  经营活动现金流入小计650,282,805.53378,912,261.171,931,145,667.071,360,151,975.06
  购买商品、接受劳务支付的现金437,808,536.13182,888,244.41,327,720,345.48906,987,403.55
  支付给职工以及为职工支付的现金153,861,860.8286,665,281.88306,806,155.78240,803,380.41
  支付的各项税费16,609,023.188,909,610.8150,760,741.5843,535,057.76
  支付其他与经营活动有关的现金91,773,481.9868,614,046.04233,238,039.95197,481,556.65
  经营活动现金流出小计700,052,902.11347,077,183.131,918,525,282.791,388,807,398.37
  经营活动产生的现金流量净额-49,770,096.5831,835,078.0412,620,384.28-28,655,423.31
二、投资活动产生的现金流量:
  收回投资收到的现金---2
  处置固定资产、无形资产和其他长期资产收回的现金净额64,330.731,066.18252,358.2339,420
  投资活动现金流入小计64,330.731,066.18252,358.2339,422
  购建固定资产、无形资产和其他长期资产支付的现金9,376,100.655,003,935.9332,581,209.4829,543,595.44
  投资支付的现金--300,0000
  支付其他与投资活动有关的现金--10,760,566.52-
  投资活动现金流出小计9,376,100.655,003,935.9343,641,77629,543,595.44
  投资活动产生的现金流量净额-9,311,769.92-5,002,869.75-43,389,417.77-29,504,173.44
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,5009,500330,000160,000
  其中:子公司吸收少数股东投资收到的现金9,5009,500330,000160,000
  取得借款收到的现金763,825,000539,095,523.181,141,610,962.66973,887,714.67
  收到其他与筹资活动有关的现金13,600,00013,600,00088,040,000132,412,000
  筹资活动现金流入小计777,434,500552,705,023.181,229,980,962.661,106,459,714.67
  偿还债务支付的现金584,895,750.38490,805,944.461,129,151,737.11888,525,222.22
  分配股利、利润或偿付利息支付的现金13,046,430.18,255,257.4529,610,441.123,688,868.93
  其中:子公司支付给少数股东的股利、利润0-1,125,0001,125,000
  支付其他与筹资活动有关的现金129,693,333.62126,446,794.6146,581,010.58179,044,648.2
  筹资活动现金流出小计727,635,514.1625,507,996.511,305,343,188.791,091,258,739.35
  筹资活动产生的现金流量净额49,798,985.9-72,802,973.33-75,362,226.1315,200,975.32
四、汇率变动对现金及现金等价物的影响-9,607.93-15,027.83-21,923.16-8,607.45
五、现金及现金等价物净增加额-9,292,488.53-45,985,792.87-106,153,182.78-42,967,228.88
  加:期初现金及现金等价物余额159,913,611.36159,913,611.36266,066,794.14266,066,794.14
  期末现金及现金等价物余额150,621,122.83113,927,818.49159,913,611.36223,099,565.26
补充资料:
  净利润24,145,664.85-41,884,746.38-
  资产减值准备-1,267,841.54-16,374,462.44-
  固定资产和投资性房地产折旧24,962,173.87-50,461,536.07-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,962,173.87-50,461,536.07-
  无形资产摊销2,183,761.5-4,335,422.75-
  长期待摊费用摊销418,523.24-1,637,814.88-
  处置固定资产、无形资产和其他长期资产的损失-20,441.06--6,876.33-
  固定资产报废损失14,842.84-312,494.18-
  公允价值变动损失--300,000-
  财务费用13,290,717.14-29,567,043.36-
  投资损失427,315.67--2,154,386.5-
  递延所得税767,073.08--1,762,484.61-
  其中:递延所得税资产减少752,153.65--1,850,272.38-
    递延所得税负债增加14,919.43-87,787.77-
  存货的减少10,128,112.92-15,792,638.14-
  经营性应收项目的减少-84,890,955.54--520,644,201.87-
  经营性应付项目的增加-41,084,994.36-369,139,303.32-
  现金的期末余额150,621,122.83-159,913,611.36-
  减:现金的期初余额159,913,611.36-266,066,794.14-
  现金及现金等价物的净增加额-9,292,488.53--106,153,182.78-
公告日期2026-08-182026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑